Northern Trust’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Buy |
286,700
+39,395
| +16% | +$185K | ﹤0.01% | 3224 |
|
|
2025
Q1 | $903K | Sell |
247,305
-6,366
| -3% | -$23.2K | ﹤0.01% | 3328 |
|
|
2024
Q4 | $1.2M | Buy |
253,671
+2,873
| +1% | +$13.6K | ﹤0.01% | 3309 |
|
|
2024
Q3 | $2.33M | Buy |
250,798
+59,847
| +31% | +$557K | ﹤0.01% | 2903 |
|
|
2024
Q2 | $1.1M | Sell |
190,951
-4,291
| -2% | -$24.7K | ﹤0.01% | 3202 |
|
|
2024
Q1 | $1.31M | Sell |
195,242
-4,032
| -2% | -$27.1K | ﹤0.01% | 3187 |
|
|
2023
Q4 | $1.29M | Sell |
199,274
-2,037
| -1% | -$13.1K | ﹤0.01% | 3221 |
|
|
2023
Q3 | $1.01M | Sell |
201,311
-854
| -0.4% | -$4.27K | ﹤0.01% | 3295 |
|
|
2023
Q2 | $1.42M | Buy |
202,165
+16,090
| +9% | +$113K | ﹤0.01% | 3209 |
|
|
2023
Q1 | $1.15M | Buy |
186,075
+4,662
| +3% | +$28.9K | ﹤0.01% | 3175 |
|
|
2022
Q4 | $1.16M | Sell |
181,413
-2,736
| -1% | -$17.5K | ﹤0.01% | 3206 |
|
|
2022
Q3 | $1.58M | Sell |
184,149
-2,849
| -2% | -$24.4K | ﹤0.01% | 3134 |
|
|
2022
Q2 | $2.54M | Buy |
186,998
+18,536
| +11% | +$252K | ﹤0.01% | 2921 |
|
|
2022
Q1 | $2.57M | Sell |
168,462
-2,014
| -1% | -$30.7K | ﹤0.01% | 2967 |
|
|
2021
Q4 | $3.9M | Sell |
170,476
-4,596
| -3% | -$105K | ﹤0.01% | 2843 |
|
|
2021
Q3 | $2.44M | Buy |
175,072
+12,172
| +7% | +$170K | ﹤0.01% | 3173 |
|
|
2021
Q2 | $1.74M | Buy |
162,900
+78,604
| +93% | +$839K | ﹤0.01% | 3395 |
|
|
2021
Q1 | $1.11M | Sell |
84,296
-4,142
| -5% | -$54.5K | ﹤0.01% | 3543 |
|
|
2020
Q4 | $1.79M | Buy |
+88,438
| New | +$1.79M | ﹤0.01% | 3243 |
|